| Source publication date | (updated; first published 2026-04-07) |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Testosterone and hormone clinic or telehealth website |
| Population | Men |
| Source | FormBlends |
| URL | formblends.com/articles/trt-hub/trt-in-40s-guide (opens in a new tab) |
Specific Claim Evaluated
Clinical studies show that 39% of men over 45 have testosterone levels below 300 ng/dL, and properly monitored testosterone therapy may reduce cardiovascular risk.
Primary Research Supporting or Contradicting the Claim
The 38.7% figure comes from men aged 45 years or older presenting to US primary care practices, a population enriched for obesity, diabetes and hypertension (Mulligan et al., 2006). TRAVERSE showed that testosterone was noninferior to placebo for major adverse cardiac events, not that it reduced them (Lincoff et al., 2023).
Corrected Evidence-Based Interpretation
About 39% of men aged 45 or older attending primary care had a single total testosterone below 300 ng/dL; this is not the prevalence in all men over 45 or of clinical hypogonadism. Testosterone therapy does not reduce cardiovascular risk.
Rationale for Grade
The page applies a primary care sample to all men over 45 without stating the population or that the figure is biochemical, and it presents a noninferiority result as possible risk reduction. Both are misreadings of the source evidence that make treatment appear more widely indicated and more beneficial than the data show.
References
- Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. PMID
Supporting excerpt: "noninferior to placebo with respect to the incidence of major adverse cardiac events" - Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762-769. PMID
Supporting excerpt: "in men aged > or = 45 years presenting to primary care offices"